¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"blood group polysaccharide"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
¿µ¹® blood pressure ÇÑ±Û Ç÷¾Ð
¼³¸í   
  Ç÷¾ÐÀ̶õ Ç÷°ü¿¡ °É¸®´Â ¾Ð·ÂÀ» ¸»Çϴ °ÍÀ¸·Î ´ë°³ Æ¯º°ÇÑ ¼³¸íÀÌ ¾øÀ¸¸é µ¿¸ÆÀÇ ¾Ð·ÂÀ» ¸»ÇÑ´Ù. Ç÷¾Ð¿¡´Â ¼öÃà±âÇ÷¾Ð(systolic blood pressure)°ú À̿ϱâÇ÷¾Ð(diastolic blood pressure)ÀÌ ÀÖ´Ù. ¼öÃà±âÇ÷¾ÐÀ̶õ ½ÉÀåÀÌ ¼öÃàÇÒ °æ¿ì¿¡ µ¿¸Æ¿¡ °É¸®´Â ¾Ð·ÂÀ» ¸»Çϰí, À̿ϱâ Ç÷¾ÐÀ̶õ ½ÉÀåÀÌ ÀÌ¿ÏÇÒ °æ¿ì¿¡ µ¿¸Æ¿¡ °É¸®´Â ¾Ð·ÂÀ» ¸»ÇÑ´Ù. ´ç¿¬È÷ ¼öÃà±â Ç÷¾ÐÀÌ À̿ϱâ Ç÷¾Ðº¸´Ù ³ô´Ù. Ç÷¾ÐÀ» ¸»ÇÒ ¶§¿¡ ¿¹¸¦ µé¾î 120/80mmHgÀ̶ó°í Àû´Â °ÍÀÇ ¾ÕÀÇ °ÍÀº ¼öÃà±â Ç÷¾ÐÀ» ÀǹÌÇÏ°í µÚ¿¡ Àû´Â 80Àº À̿ϱâ Ç÷¾ÐÀ» ÀǹÌÇÑ´Ù.
¿µ¹® blood ÇÑ±Û Ç÷¾×, ÇÇ
¼³¸í   
  ¼øÈ¯±â, Áï ½ÉÀå°ú Ç÷°ü ¾ÈÀ» ¼øÈ¯Çϴ À¯µ¿¼ºÀÇ Á¶Á÷À» ¸»ÇÑ´Ù. Ç÷¾×Àº Àüü Ã¼ÁßÀÇ ¾à 8%¸¦ Â÷ÁöÇϸç, ºñÁßÀº 1,056~1,059, Á¡µµ´Â ¾à 4.5, pH´Â 7.4ÀÌ´Ù. Ç÷¾×Àº ¾×ü¼ººÐÀΠÇ÷Àå°ú °Å±â¿¡ ¶°µ¹°í Àִ ¼¼Æ÷¼ººÐÀ¸·Î ±¸¼ºµÇ¾î ÀÖ´Ù. Ç÷ÀåÀº Àüü Ç÷¾×ÀÇ 55%¸¦ Â÷ÁöÇϸ砼öºÐ, ´Ü¹éÁú, Ç÷´ç, Áö¹æÁú, ¹«±â¿°·ù, Áú¼ÒÈ­ÇÕ¹°·Î ÀÌ·ç¾îÁø´Ù. ¼¼Æ÷¼ººÐÀº Àüü Ç÷¾×ÀÇ 45%¸¦ Â÷ÁöÇϸç ÀûÇ÷±¸, ¹éÇ÷±¸, Ç÷¼ÒÆÇÀ¸·Î ÀÌ·ç¾îÁ® ÀÖ´Ù. Ç÷¾×ÀÇ ÁÖ¿ä ±â´ÉÀº Àü½Å Á¶Á÷À¸·Î »ê¼Ò¿Í ¿µ¾çºÐ °°Àº ÇÊ¿äÇÑ ¹°ÁúÀ» ¿î¹ÝÇϸ砺ÒÇÊ¿äÇÑ ¹°ÁúÀ» ¹è¼³±â°üÀ¸·Î ¿î¹ÝÇϴ ÀÏÀÌ´Ù. ±× ¹Û¿¡ »ýü¿¡ Çطο°ÁúÀ̳ª ¼¼±ÕÀ» Á¦°ÅÇϰí, ³»ºÎȯ°æÀÇ Çâ»ó¼ºÀ» À¯ÁöÇϸç, Ã¼¿ÂÀ¯Áö¿Í »ýü ¹æ¾î ±â´ÉÀ» ÇÑ´Ù. »ç¶÷ÀÇ Ç÷¾×Àº ¿©·¯ °¡Áö ¼¼Æ÷ Ç÷±¸¿Í ±× ¼¼Æ÷¸¦ Æ÷ÇÔÇϴ ¸¼Àº ¾×üÀΠÇ÷Àå·Î ±¸¼ºµÇ¾î ÀÖ´Ù. Ç÷±¸´Â ÀûÇ÷±¸, ¹éÇ÷±¸, Ç÷¼ÒÆÇÀ¸·Î ±¸¼ºµÇ¾î ÀÖ´Ù. ÀûÇ÷±¸´Â ºÓÀº »öÀ» ¶ì´Â ¼¼Æ÷·Î »ê¼Ò¸¦ ¸öÀÇ Á¶Á÷À¸·Î ¿î¹ÝÇϴ ¿ªÇÒÀ» ÇÑ´Ù. Ç÷¼ÒÆÇÀº Ç÷¾×ÀÀ°í¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϴ ¼¼Æ÷ÀÌ´Ù.
  
  ¹éÇ÷±¸´Â Àΰ£ÀÇ ¸é¿ª¿¡ °ü°èÇϴ ¼¼Æ÷À̸砱¸Ã¼ÀûÀ¸·Î ´ÙÀ½°ú °°Àº ¼¼Æ÷µéÀÌ ÀÖ´Ù.
  
  1.°ú¸³±¸(granulocyte): °ú¸³±¸¶õ ¹éÇ÷±¸ÀÇ 60%¸¦ Â÷ÁöÇϸç, ¼¼Æ÷¼Ó¿¡ Æ¯ÀÌÇÑ °ú¸³À» °¡Áö°í Àִ ¼¼Æ÷À̸ç, ´ÙÀ½°ú °°Àº 3°¡ÁöÀÇ ¼¼Æ÷°¡ À̰÷¿¡ Æ÷ÇÔÀÌ µÈ´Ù.
  
    -È£¿°±â±¸(basophil): ¿°±â¼º¿°»ö¾à¿¡ Àß ¿°»öµÇ´Â °ú¸³À» °¡Áö°í ÀÖ´Ù. ºÒ±ÔÄ¢ÇÑ ¸ð¾çÀÇ ¼¼Æ÷·Î Çª¸¥ »öÀ» ¶ì´Â °ú¸³ÀÌ ³Ê¹« ¸¹ÀÌ À־ ÇÙÀÌ Àß º¸ÀÌÁö ¾Ê´Â´Ù.
  
    -È£»ê±¸(eosinophil): »ê¼º¿°»ö¾à¿¡ Àß ¿°»öµÇ´Â °ú¸³À» °¡Áö°í ÀÖ°í, ´ë°³ ±â»ýÃæÀÇ °¨¿°À̳ª, ¾Ë·¯Áö¿¡¼­ ¸¹ÀÌ Áõ°¡ÇÑ´Ù. ´ë°³ 2°³ÀÇ ÇÙÀ» °¡Áö°í ÀÖÀ¸¸ç ÇÙ»çÀÌ¿¡ °¡´Â ½Ç°°Àº °ÍÀ¸·Î À̾îÁ® ÀÖ´Ù.
  
    -È£Áß±¸(neutrophil): »ê¼º¿°»ö¾àÀ̳ª ¿°±â¼º¿°»ö¾à¿¡ ÀÇÇÏ¿© ¸ðµÎ Àß ¿°»öµÇ´Â °ú¸³À» °¡Áö´Â ¼¼Æ÷·Î ´ë°³ 3°³ÀÇ ÇÙÀ» °¡Áø´Ù. ±×¸®°í ÇÙ»çÀÌ¿¡ °¡´Â ½Ç°°Àº ±¸Á¶¹°ÀÌ À־ ÇÙÀ» ¼­·Î À̾îÁÖ°í ÀÖ´Ù.
  
  2.´ÜÇÙ±¸(monocyte): ´Ù°¢Çü¸ð¾çÀ» °¡Áø ¼¼Æ÷·Î °ú¸³À» °¡Áö°í ÀÖÁö ¾Ê´Ù. ¿Ü°è·ÎºÎÅÍ µé¾î¿Â ¹°ÁúÀ» Àâ¾Æ¸Ô´Â ¿ªÇÒ°ú ±×°Í¿¡ ´ëÇÑ Á¤º¸¸¦ Á¦°øÇϴ ¿ªÇÒÀ» ÇÏ¿© ¸é¿ª¿¡ °ü°èÇÑ´Ù. À̰ÍÀÌ Ç÷¾× Áß¿¡ Á¸ÀçÇÏÁö ¾Ê°í Á¶Á÷¿¡ °íÁ¤µÇ¾î Àִ °æ¿ì¿¡ À̰ÍÀ» Å«Æ÷½Ä¼¼Æ÷¶ó°í ÇÑ´Ù.
  
  3.¸²ÇÁ±¸(lymphocyte): ÀÛÀº ¿øÇüÀÇ ¼¼Æ÷·Î ¸é¿ª¿¡ ÁßÃßÀûÀΠ¿ªÇÒÀ» ÇÑ´Ù.
¿µ¹® blood gas ÇÑ±Û Ç÷¾×°¡½º, Ç÷¾×±âü
¼³¸í   
  Ç÷¾× ¼Ó¿¡ ¿ëÇØµÇ¾î Àִ »ê¼Ò, ÀÌ»êȭź¼Ò, Áú¼Ò µûÀ§ÀÇ ±âü. Ç÷¾×ÀÇ »ê¼º-¿°±â¼ºÀÇ Á¤µµ¸¦ ÃøÁ¤ÇÒ ¼ö ÀÖ´Ù.
¿µ¹® blood test ÇÑ±Û Ç÷¾×°Ë»ç
¼³¸í   
  Ç÷¾×ÇüÀ̳ª Áúº´ À¯¹« µûÀ§¸¦ ¾Ë±â À§ÇÏ¿© ÇǸ¦ »Ì¾Æ ÇàÇϴ °Ë»ç. ¸ö ÀüüÀÇ Àå±â³ª Á¶Á÷¿¡ º´ÅͰ¡ ÀÖÀ¸¸é À̵頼ººÐ¿¡ º¯È­°¡ ÀÖ°Ô µÇ¾î Áø´Ü¿¡ Å« µµ¿òÀ» ÁØ´Ù.
¿µ¹® blood-brain barrier ÇÑ±Û Ç÷¾×³úÀ庮
¼³¸í   
  Ç÷¾×À¸·ÎºÎÅÍ ³ú·Î´Â ÁöÁú¿ëÇØ¼ºÀÌ ³ôÀº ¾à¹°¹Û¿¡ ÀÌÇàµÇÁö ¾Ê´Â´Ù. ¼ö¿ë¼ºÀÇ ¾à¹°À» ³ú·Î ÀÌÇàµÇÁö ¾Ê°Ô Çϰí Àִ °ÍÀÌ Ç÷¾×³úÀ庮À̸砳úÀÇ ¸ð¼¼Ç÷°ü ³»ÇǼ¼Æ÷, ¸ð¼¼Ç÷°ü ÁÖÀ§ÀÇ ¼¼Æ÷°¡ À庮ÀÌ µÇ°í ÀÖ´Ù. ¹°Áú±³È¯Àº ¼öµ¿È®»ê¿¡ ÀÇÇØ ÀÌ·ç¾îÁöÁö¸¸, ³úÀÇ »ý¸®Àû È°µ¿¿¡ ÇÊ¿äÇÑ ¹°ÁúÀº ÀÌ¿ÂÇüÀ̶󵵠´ãü¸¦ ÅëÇØ ÀÌÇàµÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • group-specific
    ±ºÆ¯ÀÌ-
  • group-specific antigen
    ¹«¸®Æ¯ÀÌÇ׿ø, ±ºÆ¯ÀÌÇ׿ø
  • high risk group
    °íÀ§Ç豺
  • haptenic group
    ºÒ¿ÏÀüÇ׿ø±º, ÇÕÅÙ±º
  • linkage group
    ¿¬°ü±º
  • low risk group
    ÀúÀ§Ç豺
  • methyl group
    ¸ÞÆ¿±â
  • osmophore group
    ¹ßÇâ´Ü(Û¡úÅÓ¥)
  • prosthetic group
    1. º¸°áºÐÀÚ´Ü 2. º¸°á¿øÀÚ´Ü
  • soluble group
    °¡¿ëÇØ±º
  • self-help group
    ÀÚ°¡µµ¿òÁý´Ü
  • arterial blood
    µ¿¸ÆÇ÷¾×, µ¿¸ÆÇÇ
  • arterial blood gas
    µ¿¸ÆÇ÷°¡½º
  • arterial blood gas analysis
    µ¿¸ÆÇ÷°¡½ººÐ¼®
  • artificial blood
    ÀΰøÇ÷¾×
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • blood film
    Ç÷¾×Æì¹Ù¸¥Ç¥º», Ç÷¾×µµ¸»
  • blood flow
    Ç÷·ù
  • blood pressure fluctuation
    Ç÷¾Ðº¯µ¿, Ç÷¾Ð±âº¹
  • arterial blood gas
    µ¿¸ÆÇ÷°¡½º
  • blood grouping
    Ç÷¾×Çü°Ë»ç
  • blood gas
    Ç÷¾×°¡½º
  • blood loss
    ½ÇÇ÷, Ç÷¾×»ó½Ç
  • blood coagulation mechanism
    Ç÷¾×ÀÀ°í±âÀü
  • blood urea nitrogen
    Ç÷¾×¿ä¼ÒÁú¼Ò
  • blood pressure
    Ç÷¾Ð
  • blood product
    Ç÷¾×Á¦Á¦
  • portal blood pressure
    ¹®¸Æ¾Ð
  • blood flow rate
    Ç÷·ù·®, Ç÷·ù¼Óµµ
  • arterial blood gas study
    µ¿¸ÆÇ÷°¡½ººÐ¼®
  • blood sugar
    Ç÷´ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • group-specific
    ±ºÆ¯ÀÌ-
  • glucophore group
    ´ã´ç±â
  • green or yellow vegetable group
    ³ìȲ»öä¼Ò·ù
  • group hospital
    º´¿øÁ¶ÇÕ
  • group medicine
    Áý´ÜÁø·á, Çùµ¿Áø·á
  • group practice
    Áý´Ü°³¾÷
  • group psychotherapy
    Áý´ÜÁ¤½Å¿ä¹ý
  • group displacement law
    Áý´Üº¯À§¹ýÄ¢
  • group fascicular repair
    ½Å°æ¼¶À¯´Ù¹ß±ººÀÇÕ(¹ý)
  • group reference value
    Áý´Ü±âÁØÄ¡
  • haptenic group
    ºÒ¿ÏÀüÇ׿ø±º, ÇÕÅÙ±º
  • high risk group
    °íÀ§Çèµµ±º
  • index group
    ÃʹßȯÀÚ±º
  • labile methyl group
    ºÒ¾ÈÁ¤¸ÞÆ¿±â
  • linkage group
    ¿¬°ü±º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Lutheran blood groups
    ·çÅ×¶õÇ÷¾×±º
  • Lutheran s blood groups
    ·çÅ×¶õÇ÷¾×±º.
  • MBP=£¾mean blood pressure
    Áß°£Ç÷¾Ð ¡ìÀÏÀÎÀÇ¡í, Æò±ÕÇ÷¾Ð.
  • Manson blood fluke
    ¸¸¼ÕÇ÷ÈíÃæ
  • OMNISTIK blood gas syringe
    ¿È´Ï½ºÆ½Ç÷¾×°¡½ºÁÖ»ç±â
  • RBC=£¾red blood cell
    ÀûÇ÷±¸.
  • Schaedler blood agar
    ¼¨µé·¯Ç÷¾×ÇÑõ
  • accessory blood vessel
    ºÎÇ÷°ü, Á¾¼ÓÇ÷°ü
  • arterial blood
    µ¿¸ÆÇ÷.
  • arterial blood gas
    µ¿¸ÆÇ÷°¡½º
  • arterial blood gas study
    µ¿¸ÆÇ÷ °¡½ººÐ¼®
  • arterial blood oxygen tension
    µ¿¸ÆÇ÷»ê¼Ò Àå·Â.
  • arterial blood pressure
    µ¿¸ÆÇ÷¾Ð.
  • artificial blood
    ÀΰøÇ÷¾×
  • artificial blood vessel
    ÀΰøÇ÷°ü(¡­Ç÷°ü).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • atomic group
    ¿øÀÚ´Ü.
  • audiometry, group
    Áý´Üû·Â°Ë»ç
  • basic food group
    ±âÃʽÄǰ±º(¡­ãÝù¡ÏØ).
  • behavioral group therapy
    Áý´ÜÇൿġ·á(¿ä¹ý)
  • borderline group
    °æ°è±º(ÌÑÍ£ÏØ).
  • carbohydrate, group-specfic C
    ±ºÆ¯ÀÌ C ź¼öÈ­¹°
  • coliform group
    ´ëÀå±Õ±º
  • commutative group
    °¡È¯±º(˧̷˴).
  • commutator group
    ±³È¯ÀÚ±º(ÊÙË´).
  • complementation group
    »óº¸¼º Áý´Ü
  • complementophil group
    º¸Ã¼Ä£È­±â.
  • control group
    ´ëÁ¶±º(ÓßðÎÏÛ)
  • control group
    ´ëÁ¶±º(ËÀ̡˴).
  • determinant group
    °áÁ¤±º(¡­ÏØ).
  • diagnosis related group(DRG)
    Áø´Ü¸íº° ±º, À¯»çÇÑ Áø´Ü¸íµé³¢¸® ¹­¾î À̸¦ ´ÜÀ§·Î ÀÇ·áºñ¸¦ ÁöºÒÇÏ´Â ¹æ¹ý
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • carbonyl group
    Ä«¸£º¸´Ò±â(Ðñ)
  • carboxyl group
    Ä«¸£º¹½Ç±â(Ðñ)
  • complementation group
    »óº¸±º(ßÓÜÍÏØ)
  • critical group
    ÀӰ豺(×üÍ£ÏØ)
  • diazo group
    µð¾ÆÁ¶ ±â(Ðñ)
  • diazonium group
    µð¾ÆÁ¶´½ ±â(Ðñ)
  • earthy group
    Å伺±â(÷ÏàõÐñ)
  • end-group analysis
    Á¾´Ü±â ºÐ¼® (ðûÓ®ÐñÝÂà°)
  • fatty acyl group
    Áö¹æ(ò·Û¸) ¾Æ½Ç±â(Ðñ)
  • fidelity group
    Á¤È®µµ ±â(ïáü¬ÓøÐñ)
  • formimino group
    Æ÷¸§À̹̳ë±â(Ðñ)
  • formyl group
    Æ÷¸£¹Ð±â(Ðñ)
  • functional group
    ÀÛ¿ë±â(íÂéÄÐñ)
  • functional group isomer
    ÀÛ¿ë±â(íÂéÄÐñ) À̼ºÃ¼(ì¶àõô÷)
  • glucosyl group
    ±Û·çÄڽDZâ(Ðñ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • systemic blood pressure
    üÇ÷¾Ð
  • white blood cell
    ¹éÇ÷±¸
  • whole blood
    ÀüÇ÷
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PEA pelvic examination under anesthesia; phenylethyl alcohol; phenylethylamine; polysaccharide egg antig...
PPS Personal Preference Scale; physician, patient and society [course]; polyvalent pneumococcal polysacc...
PPV pneumococcal polysaccharide vaccine; porcine parvovirus; positive predictive value; positive pressur...
PS pacemaker syndrome; paired stimulation; paradoxical sleep; paraspinal; parasympathetic; Parkinson sy...
PSA parasternal short axis; pleomorphic salivary gland adenoma; polyethylene sulfonic acid; polysacchari...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
group II group I
Group III group
C-Ps C polysaccharide
CP Capsular polysaccharide
EPS Extracellular polysaccharide
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • autologous blood recovery system
    ÀÚ°¡ Ç÷¾× ȸº¹ ÀåÄ¡
  • automated noninvasive blood pressure device
    ºñħ½ÀÀû ÀÚµ¿ Ç÷¾Ð±â
  • basal blood pressure
    ±âÀú Ç÷¾Ð
  • black blood imaging
    ÈæÇ÷·ù ¿µ»ó
  • blood
    ÇÇ, Ç÷¾×
    1. ¸Æ°ü°è¸¦ È帣°í ÀÖ´Â ¾×ü·Î ¼¼Æ÷ ¼ººÐÀÎ Ç÷±¸¿Í Ç÷ûÀ¸·Î ±¸¼ºµÈ´Ù. ½ÉÀå ¹× Ç÷°ü Áï ¼øÈ¯°è¸¦ ä¿ì°í ÀÖ´Â ¾×üÀÌ´Ù. 2. ÇÇ, ½ÉÀå, µ¿¸Æ, ¸ð¼¼Ç÷°ü ¹× Á¤¸Æ³»¸¦ ¼øÈ¯Çϸ鼭 ½Åü³» ¼¼Æ÷¿¡ ¿µ¾çºÐ°ú »ê¼Ò¸¦ ¿î¹ÝÇÏ´Â ¾×üÀ̸ç, ÀûÇ÷±¸, ¹éÇ÷±¸, Ç÷¼ÒÆÇ µîÀ» Æ÷ÇÔÇÑ À¯Çü ¼ººÐ°ú Ç÷ÀåÀ¸·Î ±¸¼ºµÇ¾î ÀÖ´Ù. 3. ²öÀû²öÀûÇÑ ¾×ü·Î¼­, ÀûÇ÷±¸ÀÇ Ç÷»ö¼Ò ?¹®¿¡ ¼±È«»öÀ» ¶è´Ù. 4. Ç÷°ü ¼ÓÀ» È帣°í ÀÖ´Â ¾×»óÀÇ Á¶Á÷. ¼±¸íÇÑ Àû»öÀ» ¶ì°í ÀÖ°í ºÒÅõ¸íÇÏ¸ç ±ÕÀÏÇÏ°Ô º¸ÀδÙ. ±×·¯³ª Ç÷¾×ÀÇ ÀÛÀº ¹æ¿ïÀ» À¯¸®ÆÇ¿¡ ¾ã°Ô Æì°í Çö¹Ì°æÀ¸·Î º¸¸é Åõ¸íÇÑ ¾×ü ¼Ó¿¡ Ç÷±¸°¡ ºÎÀ¯Çϰí ÀÖ¾î ±ÕÀÏÇÏÁö ¾ÊÀ½À» ¾Ë ¼ö ÀÖ´Ù. Ç÷¾×ÀÇ ÁÖµÈ ¿ªÇÒÀº °¢Á¾ ¹°ÁúÀÇ ¿î¹ÝÀ̸ç, Æó¿¡¼­ ¼·ÃëÇÑ »ê¼Ò³ª ¼ÒÈ­°ü¿¡¼­ Èí¼öÇÑ ¿µ¾ç¼Ò µîÀ» Àü½ÅÀÇ ¸ðµç ¼¼Æ÷·Î º¸³»°í ¹Ý´ë·Î ¼¼Æ÷¿¡¼­ ¸¸µé¾îÁø ź»ê°¡½º³ª ³ëÆó¹°À» ¿î¹ÝÇØ¼­ Æó, ½ÅÀå, ÇǺΠµîÀ» ÅëÇØ¼­ ¸ö¹ÛÀ¸·Î ¹è¼³ÇÑ´Ù. ¶Ç °ñ°Ý±ÙÀ̳ª °£°ú °°ÀÌ ¿­ »ý»êÀÌ ¿Õ¼ºÇÑ °÷À¸·ÎºÎÅÍ ´Ù¸¥ ºÎºÐÀ¸·Î ¿­À» ¿Å°Ü¼­ ü¿­ÀÇ ºÐÆ÷¸¦ ±ÕµîÇÏ°Ô Çϰí, ÇǺο¡¼­ ¹æ¿­ÇÏ¿© ü¿ÂÀ» ÀÏÁ¤ÇÏ°Ô À¯Áö½ÃŰ´Â µ¥µµ °ü¿©ÇÑ´Ù. Ç÷¾×·®Àº üÁßÀÇ ¾à 8 %, ºñÁßÀº 1.06À̹ǷΠüÁßÀÌ 60 kgÀÎ ¶§ ¾à 4.5§¤°¡ µÈ´Ù. Ç÷¾×·®Àº °ÅÀÇ ÀÏÁ¤Çؼ­ ¾×ü¸¦ ¼·ÃëÇßÀ» ¶§³ª ÀûÀº ¾çÀÇ ÃâÇ÷ÀÌ ÀÖÀ» ¶§µµ Ç÷°ü ¼ÓÀÇ ¼øÈ¯ Ç÷¾×·®À» ÀÚÀ²ÀûÀ¸·Î Á¶ÀýÇÏ¿© Àüü Ç÷¾×·®Àº º¯ÇÏÁö ¾Ê´Â´Ù. ÇÑÆí, ´ë·®ÀÇ ¹°À» ¸¶¼ÌÀ» ¶§ ¼öºÐÀº °ð Ç÷¾×¿¡¼­ Á¶Á÷À¸·Î ³ª°¡°Å³ª ½ÅÀåÀ¸·ÎºÎÅÍ ¹è¼³µÈ´Ù. Ç÷¾×ÀÇ Á¡Á¶µµ´Â ¹°ÀÇ ¾à 5¹èÀ̰í, ÁÖ·Î Ç÷±¸ ¼ö¿¡ µû¶ó º¯ÇÑ´Ù. ºóÇ÷ÀÏ ¶§Ã³·³ ÀûÇ÷±¸°¡ °¨¼ÒÇϸé Á¡Á¶µµ°¡ ³·¾ÆÁ®¼­ Ç÷¾×ÀÌ Ç÷°ü ³»¸¦ È带 ¶§ ÀúÇ×ÀÌ °¨¼ÒµÇ¹Ç·Î Ç÷¾ÐÀÌ ¶³¾îÁø´Ù. µû¶ó¼­ Ç÷¾×ÀÇ Á¡Á¶µµ°¡ Ç÷¾ÐÀ» À¯ÁöÇÏ´Â µ¥¿¡ Áß¿äÇÑ ±¸½ÇÀ» Çϰí ÀÖÀ½À» ¾Ë ¼ö ÀÖ´Ù. Ç÷¾×ÀÇ »ïÅõ¾ÐÀº 6.7±â¾ÐÀ¸·Î 0.9 %ÀÇ ½Ä¿°¼ö¿Í °°´Ù. ¸¸¾à Ç÷¾×º¸´Ù ³·Àº »ïÅõ¾ÐÀÇ ½Ä¿°¼ö¿¡ Ç÷¾×À» ³ÖÀ¸¸é Ç÷±¸ ¼Ó¿¡ ¼öºÐÀÌ »¡·Á µé¾î°¡ ºÎÇ®¾î ¸¶Ä§³»´Â ÆÄ±«µÈ´Ù. À̰ÍÀ» ¿ëÇ÷À̶ó°í ÇÑ´Ù. ¶Ç ¹Ý´ë·Î Ç÷¾×º¸´Ù ³ôÀº »ïÅõ¾ÐÀÇ ½Ä¿°¼ö ¾È¿¡¼­´Â Ç÷±¸ ¼ÓÀÇ ¼öºÐÀÌ ¹ÛÀ¸·Î ³ª¿Í Ç÷±¸´Â ¿À±×¶óµé°í ¸¸´Ù. ±×¸®°í Ç÷¾×°ú °°Àº »ïÅõ¾ÐÀÇ ½Ä¿°¼ö¸¦ »ý¸®Àû ½Ä¿°¼ö¶ó ÇÑ´Ù. Ç÷¾×ÀÇ
  • blood agar
    Ç÷¾× ÇÑõ
  • blood alcohol level
    Ç÷Áß ¾ËÄÚ¿Ã ³óµµ
  • blood blister
    ¼ÒÇ÷Á¾
    Ç÷¾×¼º ³»¿ë¹°À» °¡Áø ÀÛÀº ¼öÆ÷·Î¼­ ²¿ÁýÈ÷°Å³ª Ÿ¹Ú»óÀ¸·Î »ý±âÁö¸¸ °¡²û Áö¼ÓÀûÀÎ ¸¶Âû¿¡ ÀÇÇØ¼­µµ »ý±ä´Ù.
  • blood capillary
    ¸ð¼¼Ç÷°ü
    ¼Òµ¿¸Æ°ú ¼ÒÁ¤¸ÆÀ» ¿¬°áÇÏ´Â ¹Ì¼¼ÇÑ Ç÷°ü. ÀÌ º®Àº Ç÷¾×°ú Á¶Á÷¾×ÀÇ ¿©·Á ¹°ÁúÀ» ±³È¯Çϱâ À§ÇÑ ¹ÝÅõ¸·À¸·Î ÀÛ¿ëÇÑ´Ù.
  • blood cell counter
    Ç÷±¸ °è¼ö±â
  • blood center
    Ç÷¾×¿ø
    µ¿ÀǾî=blood transfusion service. ¼öÇ÷¿¡ ÇÊ¿äÇÑ Ç÷¾×À» äÇ÷, Á¶Á¦, º¸Á¸ÇÏ°í °ø±ÞÇÏ´Â ±â°ü. 1937³â ¹Ì±¹ ½ÃÄ«°íÀÇ ÄîÄ«¿îƼ
  • blood cerebrospinal fluid barrier
    Ç÷³ú ô¼ö¾× À庮, Ç÷¾× ³úô¼ö¾× °ü¹®
  • blood circulation
    Ç÷¾× ¼øÈ¯
    Á½ɽǿ¡¼­ µ¿¸ÆÀ¸·Î ¾ÐÃâµÈ Ç÷¾×Àº ¸ð¼¼Ç÷°üÀ» °ÅÃļ­ Á¤¸ÆÀ¸·Î ³ª¿À°í ¿ì½É¹æÀ¸·Î ȯ·ùÇØ À̰÷¿¡¼­ ¿ì½É½Ç·Î µé¾î°£´Ù. ¿ì½É½ÇÀÇ ¼öÃàÀ¸·Î Æóµ¿¸ÆÀ¸·Î º¸³»Á® Æó ¸ð¼¼°üÀ» °ÅÃļ­ Æó Á¤¸Æ¿¡¼­ Á½ɹæÀ¸·Î µé¾î°¡°í ´Ù½Ã Á½ɽǷΠµé¾î°¡ ¸ö ¾ÈÀ» ÇѹÙÄû µ·´Ù.
  • blood clotting disturbance
    Ç÷¾× ÀÀ°í Àå¾Ö
  • blood coagulation
    Ç÷¾× ÀÀ°í
    µ¿ÀǾî=blood clotting. 1. Ç÷¾×ÀÇ ¸¹Àº ÀÀ°íÀÎÀÚ°¡ »óÈ£ÀÛ¿ëÇϰí ÇÕÃÄÁ®¼­ ÃÖÈÄ¿¡´Â ºÒ¿ë¼ºÀÇ ¼¶À¯¼Ò ±«ÀÇ Çü¼ºÀ» ÀÏÀ¸Å°´Â ¿¬¼ÓÀû ¹ÝÀÀÀÌ´Ù. 2. Ç÷¾×ÀÌ Ç÷°ü ¹ÛÀ¸·Î ³ª¿ÔÀ» ¶§ Á©¸®»óÀ¸·Î ±»¾îÁö´Â Çö»ó. À̰ÍÀº Ç÷¾× ¼Ó¿¡ ÇǺ기À̶ó°í ÇÏ´Â ½Ç ¸ð¾çÀÇ ¹°ÁúÀÌ ¼®ÃâµÇ¾î ±×¹° ¸ð¾çÀ¸·Î ¾ôÈ÷°í, ±× ¼Ó¿¡ Ç÷±¸¸¦ °¡µÎ¾î µÎ±â ¶§¹®ÀÌ´Ù. ÀÌ Ç÷±¸ µ¢¾î¸®´Â ½Ã°£ÀÌ Áö³²¿¡ µû¶ó Á¡Á¡ ¼öÃàÇÏ¿© ÀÛ¾ÆÁö¸é¼­ ´ãȲ»öÀÇ Åõ¸íÇÑ ¾×ü°¡ ½º¸ç ³ª¿Â´Ù. Ç÷±¸ÀÇ µ¢¾î¸®¸¦ Ç÷º´À̶ó Çϰí, ½º¸ç ³ª¿Â Åõ¸íÇÑ ¾×ü¸¦ Ç÷ûÀ̶ó°í ÇÑ´Ù. Ç÷¾× ÀÀ°í´Â »ý¸íÀ» À¯ÁöÇÏ´Â µ¥ ºÒ°¡°áÇÑ °ÍÀ¸·Î, ¸¸ÀÏ Ç÷¾×¿¡ ÀÌ ÀÛ¿ëÀÌ ¾øÀ¸¸é ÃâÇ÷¿¡ ÀÇÇÏ¿© °ð Á×°Ô µÈ´Ù. ÀÏ»ó»ýȰ¿¡¼­´Â ²÷ÀÓ¾øÀÌ ¿Ü»óÀ» ÀÔ°Ô µÇ°í ±×¶§ ´Ù¼Ò³ª¸¶ ¸ð¼¼Ç÷°üÀÌ ÆÄ¿­µÇ´Âµ¥, ÆÄ¼ÕºÎÀ§´Â Ç÷¾× ÀÀ°í¿¡ ÀÇÇÏ¿© ¼öº¹µÈ´Ù. Ç÷¾× ÀÀ°í°¡ ÀϾ´Â ¸ÞÄ¿´ÏÁò¿¡ ´ëÇØ¼­´Â ¸î °¡Áö ¼³ÀÌ ÀÖÁö¸¸ ¾î´À °ÍÀÌµç ±âº»ÀûÀ¸·Î´Â Ç÷¾×ÀÌ Ç÷°ü ¹ÛÀ¸·Î ³ª¿À¸é Ç÷¼ÒÆÇÀÌ ÆÄ±«µÇ¾î Æ®·Òº¸ÇÃ¶ó½ºÆ¾ÀÌ »ý±â°í, À̰ÍÀÌ Ç÷¾× ¼ÓÀÇ Ä®½· À̿°ú ÇÔ²² ÀÛ¿ëÇÏ¿© Ç÷Àå ´Ü¹éÁúÀÇ ÇϳªÀÎ ÇÁ·ÎÆ®·ÒºóÀ» Æ®·ÒºóÀ¸·Î º¯È­½ÃŲ´Ù. ÀÌ Æ®·ÒºóÀÌ ÇǺ긮³ë°Õ¿¡ ÀÛ¿ëÇÏ¿© ÇǺ기ÀÌ µÈ´Ù. ÀÌ °úÁ¤¿¡´Â Ç÷ÀåÀ̳ª Ç÷¼ÒÆÇ¿¡ ÀÖ´Â ¸¹Àº ÀÎÀÚ°¡ °ü¿©Çϴµ¥, ¿¬±¸ÀÚ¿¡ µû¶ó °¢¾ç°¢»öÀÇ À̸§À¸·Î ºÒ¸®¾î È¥¶õÀ» ÃÊ·¡Çϰí ÀÖÀ¸¹Ç·Î, ±¹Á¦Ç÷¾×ÀÀ°íÀ§¿øÈ¸¿¡¼­ À̵é ÀÎÀÚ¸¦ ¹øÈ£·Î ³ªÅ¸³»µµ·Ï °áÁ¤Çϰí ÀÖ´Ù. Á¦1»óÀÇ Æ®·Òº¸ÇÃ¶ó½ºÆ¾ÀÌ Çü¼ºµÇ´Â °úÁ¤ÀÌ °¡Àå º¹ÀâÇϰí, Ç÷¾× ÀÀ°í¿¡ °É¸®´Â ´ëºÎºÐÀÇ ½Ã°£ÀÌ ÀÌ °úÁ¤¿¡ ¼Ò¿äµÈ´Ù. Æ®·Òº¸ÇÃ¶ó½ºÆ¾ÀÌ ¸¸µé¾îÁö´Â µ¥´Â µÎ °¡Áö °æ·Î°¡ ÀÖ´Ù. óÀ½ °æ·Î´Â Ç÷°ü ¼Ó¿¡¼­ ÀÌ·ç¾îÁø´Ù. Ç÷Àå ¼Ó¿¡ À̹°Áú°ú Á¢Çϸé Ȱ¼ºÈ­µÇ´Â È¿¼Ò°¡ Àִµ¥, ÇöÀç Á¦ XIÀÎÀÚ¿Í Á¦ XIIÀÎÀÚÀÇ µÎ °¡Áö°¡ ¾Ë·ÁÁ® ÀÖ´Ù. À̰ÍÀÌ ¹æ¾Æ¼è°¡ µÇ¾î Á¦ VÀÎÀÚ, Á¦ VIIIÀÎÀÚ, Á¦ IXÀÎÀÚ µî°ú Ç÷¼ÒÆÇÀ¸·ÎºÎÅÍÀÇ ÀÎÀÚ°¡ ÀÛ¿ëÇÏ¿© Ç÷¾× Æ®·Òº¸ÇÃ¶ó½ºÆ¾ÀÌ »ý¼ºµÈ´Ù. ´Ù¸¥ ÇϳªÀÇ °æ·Î´Â Ç÷°ü ¹ÛÀÇ Á¶Á÷¿¡¼­ ÀÌ·ç¾îÁø´Ù. ÆÄ±«µÈ Á¶Á÷¿¡ Ç÷Àå ¼ÓÀÇ Á¦ VÀÎÀÚ, Á¦ VIIÀÎÀÚ, Á¦ XÀÎÀÚ µîÀÌ ÀÛ¿ëÇÏ¿© Á¶Á÷ Æ®·Òº¸ÇÃ¶ó½ºÆ¾ÀÌ »ý¼ºµÈ´Ù. Á¦2»óÀÇ Æ®·ÒºóÀÇ »ý¼º¿¡¼­´Â Ç÷¾× ¹× Á¶Á÷¿¡ »ý±ä Ȱ¼º Æ®·Òº¸ÇÃ¶ó½ºÆ¾ÀÌ Ä®½· À̿°ú ÇÔ²² Ç÷Àå ¼ÓÀÇ ÇÁ·ÎÆ®·Òºó¿¡ ÀÛ¿ëÇÏ¿© Æ®·ÒºóÀ» Çü¼ºÇÑ´Ù. ÇÁ·ÎÆ®·ÒºóÀº °£¿¡¼­ ºñŸ¹Î KÀÇ ÀÛ¿ëÇÏ¿¡ ¸¸µé¾îÁö°í, ÇìÆÄ¸°Àº ÀÌ Á¦ 2»óÀ» ¾ïÁ¦ÇÏ¿© Ç÷¾× ÀÀ°í ÀúÁö ÀÛ¿ëÀ» ³ªÅ¸³½´Ù. Á¦ 3»ó¿¡¼­´Â Æ®·ÒºóÀÌ ÇǺ긮³ë°ÕÀÇ ÆéƼµå °áÇÕÀ» ºÐÇØÇÏ¿© ÇǺ기 ¼¶À¯¸¦ ¼®Ãâ½ÃŲ´Ù. ¿©±â¿¡ Ä®½· À̿°ú ÇÔ²² Á¦ XIII ÀÎÀÚ°¡ ÀÛ¿ëÇÏ¿© ÇǺ기¸ÁÀ» ¸¸µé¾î Ç÷º´ÀÌ ¿Ï¼ºµÈ´Ù. ¿©±â¿¡¼­ »ý¼ºµÈ ÇǺ기Àº ±×´ë·Î µÎ¸é ´Ù½Ã ¿ëÇØµÇ´Âµ¥ À̰ÍÀ» ¼¶À¯¼Ò ¿ëÇØ¶ó°í ÇÑ´Ù. ÀÌ ¼¶À¯¼Ò ¿ëÇØ´Â Ç÷Àå ¼Ó¿¡ ÀÖ´Â Çö󽺹̳ë°ÕÀÌ È°¼ºÈ­ÇÏ¿© Çö󽺹ÎÀÌ µÇ°í ÇǺ기À» ³ìÀ̱⠶§¹®ÀÌ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
lewis blood-group system A group of dominantly and independently inherited antigens associated with the abo blood factors. They are glycolipids present in plasma and secretions that may adhere to the erythrocytes. The phenotype le(b) is the result of the interaction of the le gene le(a) with the genes for the abo blood groups.
(12 Dec 1998)
lutheran blood-group system A complex blood group system having pairs of alternate antigens and amorphic genes, but also subject to a dominant independently segregating repressor.
(12 Dec 1998)
actinobacteria group A group of gram-positive, heterogeneous bacteria. This group encompasses a range of morphologically, physiologically, and chemically different organisms and includes bacteria that form cocci, short rods, irregular rods, and mycelia that fragment.
(12 Dec 1998)
alkyl group <chemistry> A funtional group on an organic molecule which is derived from an alkane which has lost a hydrogen atom.
(13 Nov 1997)
aluminum group Aluminum, boron, gallium, indium, and thallium.
(05 Mar 2000)
amino group <biochemistry> An -NH2 group. Organic compounds which have this group are called amines.
(09 Oct 1997)
anterior group of axillary lymph nodes Lymph nodes located along the lateral thoracic vein; they receive the drainage of the pectoral region, including most of the drainage of the breast.
Synonym: nodi lymphatici axillaris pectorales, anterior group of axillary lymph nodes.
(05 Mar 2000)
apical group of axillary lymph nodes The group of lymph node's located at the apex of the axillary fossa that receive lymphatic drainage from other groups of axillary node's and then drain in turn into the subclavian lymphatic trunk.
Synonym: nodi lymphatici axillares apicales.
(05 Mar 2000)
Bethesda-Ballerup Group A group of citrate-utilizing, slow lactose-fermenting bacteria (family Enterobacteriaceae) which share a similar series of antigens with the lactose-fermenting citrobacters; these organisms are now included in the genus Citrobacter without a distinction between prompt and slow lactose fermentation.
(05 Mar 2000)
bunyamwera group viruses A large group of viruses from many parts of the world assigned to the bunyavirus genus of the family bunyaviridae. They are transmitted by mosquitoes and infect humans in some areas. This group contains the type species of the genus, bunyamwera virus.
(12 Dec 1998)
calcium group The metals of the alkaline earths: beryllium, magnesium, calcium, strontium, barium, and radium.
(05 Mar 2000)
california group viruses A group of viruses in the bunyavirus genus of the bunyaviridae family. They are found in temperate and arctic regions and each is closely associated with a single species of vector mosquito. The vertebrate hosts are usually small mammals but several virus species infect humans.
(12 Dec 1998)
carbonyl group A group in which an oxygen atom is double-bonded to a carbon atom: O=C. The carbon atom then has two additional bonds to attach to the rest of the molecule. Organic molecules containing a carbonyl group are a very important, major group of compounds studied in the field of organic chemistry.
(09 Oct 1997)
carboxyl group -COOH group. One of the oxygens is double-bonded to the carbon atom, making it a carbonyl group, and the other oxygen is single bonded to the carbon on one side, and single bonded to the hydrogen on the other. The remaining bond on the carbon atom is attached to the rest of the molecule. Organic molecules containing carboxyl groups are an important, major group of compounds studied in the field of organic chemistry.
(09 Oct 1997)
vanadium group Those elements resembling vanadium in chemical and metallurgical properties; included with vanadium are niobium and tantalum.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • high blood pressure
    °íÇ÷¾Ð
  • ill blood
    ¾ÇÀÇ;¾Ó½É;Àû´ë½É;¿øÇÑ
  • new blood
    (»õ·Î¿î Ȱ·Â(»ç»ó)ÀÇ ¿øÃµÀ¸·Î¼­ÀÇ)ÀþÀºÀ̵é;½ÅÀεé
  • red blood cell(corpuscle)
    ÀûÇ÷±¸
  • young blood
    ûÃáÀÇ Ç÷±â;ÀþÀºÀ̵é
  • age-group
    ¿¬·É Áý´Ü
  • group
    Áý´Ü,¶¼¸¦ Áþ´Ù,ºÐ·ùÇÏ´Ù
  • Group of 77
    77°³±¹ ±×·ì(UNÀÇ ¹«¿ª°³¹ß ȸÀÇ(UNCTAD)ÀÇ È¸¿øÀÎ ¹ßÀü µµ»ó±¹ ±×·ì)
  • Group of Seven
    G;7 ¼±Áø 7°³±¹ ±×·ì
  • code group
    ºÎÈ£±º
  • continuous group
    ¿¬¼Ó±º
  • control group
    Á¦¾îÁý´Ü;Á¶Á¾ÀåÄ¡;´ëÁ¶±º(µ¿ÀϽÇÇè¿¡¼­ ½ÇÇè¿ä°ÇÀ» °¡ÇÏÁö ¾ÊÀº ±×·ì)
  • enxounter group
    (Á¤ÀÇ)Áý´Ü °¨¼ö¼º ÈÆ·Ã ±×·ì
  • ethnic group
    (»çȸ)ÀÎÁ¾ Áý´Ü
  • focus group
    Æ÷Ä¿½º ±×·ì(Å×½ºÆ®ÇÒ »óǰ¿¡ ´ëÇØ¼­ ÅäÀÇÇÏ´Â ¼ÒºñÀÚ ±×·ì)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á